Markers of Bone Metabolism in Hemodialyses and Hemodiafiltration

Renal osteodystrophy is a common complication of chronic renal failure and renal replacement therapy. The purpose of the study was to assess whether hemodialysis (HD) or hemodiafiltration (HDF) affects bone turnover. In all, 45 HD and 17 HDF patients were evaluated with respect to bone metabolism markers. We assessed PTH; markers of bone formation-alkaline phosphatase and its bone isoform, osteocalcin; markers of bone resorption- PICP, ICTP; Ctx; β2-microglobulin; and urinary DPD. BMD were determined for femoral neck and lumbar spine (L2–L4) using DEXA. Hemodialyzed patients had lower calcidiol, calcitriol, and BMD in the femur neck, and higher phosphate, Kt/V, residual renal function, venous pH, osteocalcin, ALP, bALP, DPD, β2-microglobulin, ICTP, Ctx, osteoprotegerin, and RANKL than patients on HDF. HDF seems to ameliorate bone metabolism in comparison with HD. Bone turnover in end-stage renal failure might be affected to some extent by the choice of renal replacement therapy.

[1]  J. Małyszko,et al.  Markers of endothelial damage in patients on hemodialysis and hemodiafiltration. , 2006, JN. Journal of Nephrology (Milano. 1992).

[2]  P. Roderick,et al.  Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  A. Ruello,et al.  Osteoprotegerin and Bone Mineral Density in Hemodiafiltration Patients , 2005, Renal failure.

[4]  D. Casu,et al.  Comparison between hemofiltration and hemodiafiltration in a long-term prospective cross-over study. , 2004, Journal of nephrology.

[5]  J. Małyszko,et al.  Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. , 2003, Transplantation proceedings.

[6]  B. Jaber,et al.  A Time for Rediscovery: Chronic Hemofiltration for End‐Stage Renal Disease , 2003, Seminars in dialysis.

[7]  K. Leunissen,et al.  Optimizing renal replacement therapy--a case for online filtration therapies? , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  H. Suominen,et al.  Serum Tartrate-Resistant Acid Phosphatase 5b, but not 5a, Correlates with Other Markers of Bone Turnover and Bone Mineral Density , 2002, Calcified Tissue International.

[9]  E. Kasal,et al.  The Effect of Heparin Rinse on the Biocompatibility of Continuous Veno-Venous Hemodiafiltration , 2002, The International journal of artificial organs.

[10]  J. Małyszko,et al.  Correlations between new markers of bone formation versus bone resorption in kidney transplant recipients. , 2002, Transplantation Proceedings.

[11]  F. Ding,et al.  Online hemodiafiltration versus acetate-free biofiltration: a prospective crossover study. , 2002, Artificial organs.

[12]  S. Khosla,et al.  Minireview: the OPG/RANKL/RANK system. , 2001, Endocrinology.

[13]  B. Nederlof,et al.  Efficacy of haemodiafiltration. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  J. Małyszko,et al.  Serum Crosslaps Correlations with Serum ICTP and Urine DPD in Hemodialyzed and Peritoneally Dialyzed Patients , 2001, Nephron.

[15]  N. Garcia-Fernandez,et al.  Haemostatic changes in systemic inflammatory response syndrome during continuous renal replacement therapy. , 2000, Journal of nephrology.

[16]  H. Suominen,et al.  Tartrate‐Resistant Acid Phosphatase 5b: A Novel Serum Marker of Bone Resorption , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  S. Chandrasekhar,et al.  In Vivo Demonstration that Human Parathyroid Hormone 1–38 Inhibits the Expression of Osteoprotegerin in Bone with the Kinetics of an Immediate Early Gene , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  J. Billiouw,et al.  On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  D. Falkenhagen,et al.  Can sterile and pyrogen-free on-line substitution fluid be routinely delivered? A multicentric study on the microbiological safety of on-line haemodiafiltration. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  S. P. Walton,et al.  Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase. , 1999, Clinical chemistry.

[21]  S. K. Lee,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with , 2022 .

[22]  P. Ureña,et al.  Circulating biochemical markers of bone remodeling in uremic patients. , 1999, Kidney international.

[23]  F. Maduell,et al.  Change from conventional haemodiafiltration to on-line haemodiafiltration. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  K. Hruska.  New concepts in renal osteodystrophy. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  W. Peh.  Renal osteodystrophy. , 2002, American journal of orthopedics.

[26]  A. Scillitani,et al.  Gender Differences in Serum Markers of Bone Resorption in Healthy Subjects and Patients with Disorders Affecting Bone , 2002, Osteoporosis International.

[27]  C. de la Piedra,et al.  Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure. , 1994, Mineral and Electrolyte Metabolism.

[28]  T. Chan,et al.  Total and regional bone densities in dialysis patients. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.